Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02806336
Other study ID # E1813-R
Secondary ID 1I01RX001813-01A
Status Completed
Phase Phase 2/Phase 3
First received
Last updated
Start date October 3, 2016
Est. completion date June 30, 2022

Study information

Verified date July 2022
Source VA Office of Research and Development
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Obesity is a major risk factor for mobility problems in older adults and many older adults use a walking aid to help with their mobility. The use of a walking aid changes normal walking patterns and makes walking harder, leading people to have more functional problems. The purpose of this study is to test the effects of 12 months of a multi-modal balance intervention (MMBI) with supervised weight loss compared to MMBI only on fitness, functional performance, balance, and economy of gait. Participants will be one of 120 participants in the VAMHCS. Participation in this study is voluntary. The research will be conducted at the VAMHCS. The entire study will take approximately 4 years to complete. Subjects' participation in the study will last 24 months.


Description:

Note: new recruitment on hold due to COVID-19 Older obese adults suffer disproportionately from walking mobility limitations. Sedentary, obese older adults are at an increased risk for having or developing difficulties with mobility. These individuals are often excluded from studies due to their advanced mobility limitations. A number of studies have compared the effects of weight loss alone, exercise alone, or weight loss in combination with exercise on functional performance in older adults, but none of the studies have specifically targeted subjects who use walking assistive devices. The purpose of this study is to test the effects of a 12 month multi-modal exercise rehabilitation intervention with a nutrition program versus a nutrition program only on fitness, functional performance, mobility, and muscle mass. The results of this study will lead to new and more effective interventions that could reduce disability, fall risk, injury-related hospitalization and death in older Veterans.


Recruitment information / eligibility

Status Completed
Enrollment 37
Est. completion date June 30, 2022
Est. primary completion date June 30, 2022
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria: - Age >= 60 - BMI >= 30 kg/m2 - Dysmobility as define by 1 or more of the following: Use of or prescribed an assistive walking device, measured gait speed < 1.0 m/s, Four Square Step Test >/= 12 secs OR inability to complete the Four Square Step Test, and/or self-reported difficulty walking 1 km. - Community dwelling Exclusion Criteria: - Unable to walk >0.2 mph on a treadmill for 2 minutes - Poorly controlled hypertension >180 systolic or >100 diastolic - Episodes of acute coronary syndrome, coronary revascularization, or major cardiac/vascular procedures within the prior 6 months - NYHA Class 3 or 4 heart failure - Symptomatic angina at rest or during exercise - Syncope within the past 12 months without known cause or resolution - Chronic lung disease required oxygen dependency - Severe spinal stenosis limiting ambulation - Known dementia - Mini Mental State Exam score <24 - Transtibial or above the knee amputation - Currently enrolled and active in Gerofit or MOVE - Poorly controlled diabetes as defined by HbA1C >10% or frequent hypoglycemic episodes - Currently undergoing chemotherapy and/or radiation therapy for cancer treatment

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Multi Modal Balance Training
Group balance class, obstacle course, strengthening exercises
Weight Loss
Nutritional counseling to achieve 500 kcal standard hypocaloric diet

Locations

Country Name City State
United States Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD Baltimore Maryland

Sponsors (1)

Lead Sponsor Collaborator
VA Office of Research and Development

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in 6 minute walk distance Distance walked during the 6 minute walking test baseline, 3 months, 6 months, 12 months, 24 months
Secondary Change in VO2peak VO2peak measured during graded exercise treadmill test to volitional fatigue baseline, 6 months, 12 months, 24 months
Secondary Change in 6 minute walk with VO2 measurement 6 minute walk with submaximal assessment of oxygen uptake. baseline, 3 months, 6 months, 12 months, 24 months
Secondary Change in Muscle mass/body composition as assessed by DXA scan DXA scan baseline, 6 months, 12 months, 24 months
Secondary Change in Quality of Life, LLDFI LLDFI Questionnaires baseline, 3 months, 6 months, 12 months, 24 months
Secondary Change in gait biomechanics Gait biomechanics as assessed by walking mechanics on the GAITmat baseline, 3 months, 6 months, 12 months, 24 months
Secondary Change in short physical performance battery Component scores of the standing balance battery, usual gait speed, and repeated chair stands (which make up the short physical performance battery test); as well as overall short physical performance battery score baseline, 3 months, 6 months, 12 months, 24 months
Secondary Change in four square step test Dynamic test of balance involving change in stepping direction. baseline, 3 months, 6 months, 12 months, 24 months
Secondary Change in 8 foot up and go Time to get up from a chair and walk around a cone 8 feet away and sit back down, representing agility. baseline, 3 months, 6 months, 12 months, 24 months
Secondary Change in Muscle mass/body composition as assessed by CT scan CT scan baseline, 6 months, 12 months, 24 months
Secondary Change in ADL/IADL questionnaire Self-reported ability to complete activities of daily living and independent activities of daily living. baseline, 3 months, 6 months, 12 months, 24 months
Secondary Change in CHAMPS questionnaire Self-reported physical activities questionnaire. baseline, 3 months, 6 months, 12 months, 24 months
Secondary Change in MoCA Questionnaire assessing global cognitive function baseline, 3 months, 6 months, 12 months, 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2